SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019671
Filing Date
2023-05-09
Accepted
2023-05-09 16:11:47
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-20230331.htm   iXBRL 10-Q 2102206
2 EX-10.1 rptx-ex10_1.htm EX-10 36859
3 EX-31.1 rptx-ex31_1.htm EX-31 20548
4 EX-31.2 rptx-ex31_2.htm EX-31 20218
5 EX-32.1 rptx-ex32_1.htm EX-32 10355
6 EX-32.2 rptx-ex32_2.htm EX-32 10543
  Complete submission text file 0000950170-23-019671.txt   7691988

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rptx-20230331_cal.xml EX-101.CAL 41110
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rptx-20230331_lab.xml EX-101.LAB 384803
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rptx-20230331_pre.xml EX-101.PRE 273938
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rptx-20230331.xsd EX-101.SCH 41959
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rptx-20230331_def.xml EX-101.DEF 126462
53 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20230331_htm.xml XML 1561051
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 23902112
SIC: 2834 Pharmaceutical Preparations